Semax + Selank Blend
PH-SEMSEL-001
Specifications
Description
Semax + Selank Blend combines an ACTH(4-7) analog with a Tuftsin analog for synergistic nootropic and anxiolytic research. This combination targets complementary neuroprotective pathways.
Mechanism of Action
Semax is a synthetic analog of the ACTH(4-7) fragment that modulates BDNF expression and enhances cognitive function through multiple neurotrophic pathways. Selank is a synthetic analog of the endogenous immunomodulatory peptide Tuftsin that displays anxiolytic properties without sedation through GABAergic modulation and enkephalinase inhibition. The combination provides both cognitive enhancement and anxiolytic activity through complementary mechanisms.
Research Applications
- Combined nootropic and anxiolytic studies
- BDNF/neurotrophic factor modulation
- GABAergic pathway research
- Neuroprotection and neuroplasticity
- Cognitive enhancement under stress conditions
Product Specifications
- Composition: Semax 10mg + Selank 10mg
- Purity: ≥99% each component
- Form: Lyophilized powder
- Storage: -20°C
Documentation
Storage and Handling
- ❄️ Store lyophilized peptide at -20°C or below
- 🔒 Protect from light and moisture
- 🌡️ Allow vial to reach room temperature before opening
- 💧 Reconstitute with appropriate sterile solvent
- 📦 Aliquot to avoid repeated freeze-thaw cycles
Research Overview
Semax + Selank Blend is a synthetic peptide compound used in laboratory research settings. Researchers studying cognitive function and neuroprotection use this compound to investigate cellular signaling pathways, receptor binding affinities, and structure-activity relationships. Each batch is manufactured under controlled conditions and verified through HPLC and mass spectrometry analysis to ensure consistency across experimental replicates.
Documentation & Resources
- Certificate of Analysis for Semax + Selank Blend — batch-specific purity and identity verification
- Research Blog — protocols, guides, and peptide research literature
- Research Use Policy — handling and compliance guidelines
